Skip to main content
Top

Perceived stress in mothers of children with and without islet and coeliac autoimmunity in the ENDIA study

Published in:

Abstract

Aim/hypothesis

We aimed to assess perceived stress and influencing factors in mothers with children at risk of type 1 diabetes and coeliac disease who did, or did not, develop islet autoantibodies (IA) or coeliac autoantibodies (CA) by 4 years of age.

Methods

Maternal perceived stress was assessed postpartum and when their child was approximately 4 years of age using the Perceived Stress Scale (range 1–56) in mothers followed prospectively in the multicentre Environmental Determinants of Islet Autoimmunity (ENDIA) pregnancy–birth cohort. Data were analysed using linear mixed models.

Results

In total, 818 mothers were included (642 children had no detected IA or CA [Ab negative], 97 had IA detected [IA positive] and 79 had CA detected [CA positive]). The development of IA or CA in young children did not add significantly to the perceived stress of their mothers at a median of 1.8 [IQR 0.8–2.5] and 1.6 [IQR 0.9–2.3] years later, respectively (Ab negative, adjusted predicted mean score 23.8 [95% CI 22.7, 24.9]; IA positive, 22.8 [21.0, 24.6]; CA positive, 25.2 [23.3, 27.2]). Maternal type 1 diabetes did not alter this result. On exploratory predictor analysis a higher perceived stress score at 4 years was associated with a history of mental health illness (β=4.66 [95% CI 3.30, 6.02]) and mental health medication use (β=2.71 [0.64, 4.78]), independent of child autoantibody status or maternal type 1 diabetes status.

Conclusions/interpretation

Detection of IA or CA in their child did not increase ongoing maternal perceived stress after 1–2 years in a cohort that received consistent support and education. History of mental health illness and mental health medication use were associated with increased perceived stress in mothers regardless of their child’s autoantibody status.

Graphical Abstract

Title
Perceived stress in mothers of children with and without islet and coeliac autoimmunity in the ENDIA study
Authors
Rebecca L. Thomson
Guinevere Martin
Kelly J. McGorm
Timothy Spelman
Maria E. Craig
Megan A. S. Penno
John M. Wentworth
Peter G. Colman
Elizabeth A. Davis
Aveni Haynes
Tony Huynh
Georgia Soldatos
Jason A. Tye-Din
Helena Oakey
Jennifer J. Couper
on behalf of the ENDIA Study Group
Publication date
06-11-2025
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 2/2026
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-025-06584-3
This content is only visible if you are logged in and have the appropriate permissions.
This content is only visible if you are logged in and have the appropriate permissions.

Keynote webinar | Spotlight on progress in colorectal cancer

CRC remains a major global health burden, but advances in screening, treatment, and lifestyle-based prevention continue to reshape clinical practice. Gain insights into how the latest research can be leveraged to optimize patient care across the CRC continuum.

Prof. Antoni Castells
Prof. Harpreet Wasan
Prof. Edward Giovannucci
Watch now

Keynote webinar | Spotlight on functional neurological disorder

FND perplexes and frustrates patients and physicians alike. Limited knowledge and insufficient awareness delays diagnosis and treatment, and many patients feel misunderstood and stigmatized. How can you recognize FND and what are the treatment options?

Prof. Mark Edwards
Watch now
Video
Image Credits
Colon cancer illustration/© (M) KATERYNA KON / SCIENCE PHOTO LIBRARY / Getty Images, Human brain illustration/© (M) CHRISTOPH BURGSTEDT / SCIENCE PHOTO LIBRARY / Getty Images